Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis
William J Sandborn, Jean-Frédéric Colombel, Remo Panaccione, Parambir S Dulai, Maria Rosario, Charlie Cao, Morris Barocas, Karen Lasch;William J Sandborn;Jean-Frédéric Colombel;Remo Panaccione;Parambir S Dulai;Maria Rosario;Charlie Cao;Morris Barocas;Karen Lasch;
journal of crohn's & colitis2019Vol. 13pp. 172-
91
lasch2019journaldeep
Abstract
This GEMINI 1 post hoc analysis evaluated vedolizumab efficacy for inducing deep remission in patients with ulcerative colitis and correlation between vedolizumab trough concentrations and deep remission rates.Week 6 vedolizumab responders were re-randomized ...